8-K: FONAR Q1 FY26: Revenue Up, Profit Down Amid Buyout Talks

FONAR Corporation reported a 4% increase in Q1 FY26 revenue to $26.0 million, but net income fell 33% to $2.7 million, while management continues negotiations for a potential going-private transaction.

Summary

• Total Revenues Net increased by 4% to $26.0 million for the first quarter ended September 30, 2025, compared to $25.0 million in the corresponding quarter one year earlier.
• Consolidated Net Income decreased by 33% to $2.7 million for the quarter ended September 30, 2025, down from $4.0 million in the prior year.
• Diluted Net Income per Common Share decreased by 26% to $0.34 for the quarter ended September 30, 2025, compared to $0.46 in the prior year.
• Income from Operations decreased by 30% to $3.2 million for the quarter ended September 30, 2025, down from $4.6 million.
• Selling, general and administrative (S, G & A) expenses increased by 33% to $6.8 million for the quarter ended September 30, 2025.
• Cash and cash equivalents decreased by 4% to $54.3 million at September 30, 2025, from $56.3 million at June 30, 2025.
• Working Capital decreased by 0.3% to $127.1 million at September 30, 2025, compared to $127.5 million at June 30, 2025.
• HMCA's scan volume for the quarter was 55,106, which is 3.9% higher than the corresponding quarter of Fiscal 2025 and the second highest quarterly scan volume in HMCA history.
• A non-binding proposal for a going-private transaction from a group led by the CEO and COO is currently under negotiation by a Special Committee of independent directors.
• Share repurchases under the $9 million stock purchase plan, established in September 2022, have been suspended due to the ongoing negotiations.

Sentiment

Score: 4

Explanation: While revenue showed modest growth and operational expansion is planned, the substantial decline in net income and earnings per share, driven by increased operating costs, presents a negative financial picture. The ongoing, uncertain going-private transaction and the suspension of share repurchases add to the cautious sentiment.

Positives

• Total Revenues Net increased by 4% to $26.0 million for the quarter ended September 30, 2025, compared to the prior year.
• Revenues from the FONAR segment increased by 14% to $2.5 million for the quarter.
• Revenues from the Health Management Corporation of America (HMCA) segment increased by 3% to $23.5 million for the quarter.
• HMCA's scan volume of 55,106 was 3.9% higher than the corresponding quarter of Fiscal 2025 and represents the second highest quarterly scan volume in HMCA history.
• The company plans to expand its HMCA network by adding a second MRI at an existing Nassau County center and managing an entirely new MRI center in Nassau County later in the fiscal year.
• The Current Ratio improved to 8.6 at September 30, 2025, from 8.4 at June 30, 2025, indicating strong liquidity.
• Net Book Value per Common Share increased to $26.02 at September 30, 2025, from $25.32 at September 30, 2024.
• Total Equity increased to $161.4 million at September 30, 2025, from $160.1 million at June 30, 2025.

Negatives

• Income from Operations decreased by 30% to $3.2 million for the quarter ended September 30, 2025.
• Consolidated Net Income decreased by 33% to $2.7 million for the quarter ended September 30, 2025.
• Diluted Net Income per Common Share decreased by 26% to $0.34 for the quarter ended September 30, 2025.
• Selling, general and administrative (S, G & A) expenses increased significantly by 33% to $6.8 million for the quarter.
• Total Costs and Expenses increased by 12% to $22.8 million for the quarter.
• Cash and cash equivalents decreased by 4% to $54.3 million at September 30, 2025.
• HMCA scan volume for the quarter was 0.7% lower than the previous quarter's record high of 55,473.
• The stock repurchase plan has been suspended due to ongoing negotiations for a potential going-private transaction.

Risks

• There is no assurance that the proposed going-private transaction will be completed, which could lead to uncertainty and impact investor confidence.
• The ongoing negotiations for the potential going-private transaction may divert management's attention and resources from core business operations.
• The significant increase in selling, general and administrative expenses could continue to pressure the company's profitability if not managed effectively.
• Forward-looking statements regarding future growth and expansion may not materialize, as noted in the company's disclaimer.
• The company operates in a competitive medical imaging industry, facing potential challenges from larger, more diversified players.

Future Outlook

Management expects continued growth throughout the fiscal year, driven by the expansion of its diagnostic imaging management subsidiary, HMCA. This expansion includes plans to add a second MRI scanner at an existing Nassau County center in the second quarter and manage an entirely new MRI center in Nassau County later in the fiscal year. The company is also actively searching for new locations to profitably enhance its existing New York and Florida networks.

Management Comments

• "Our diagnostic imaging management subsidiary, Health Management Company of America (HMCA), the Company's primary source of revenue and profit, continues to grow."
• "We're off to a good start and expect to continue growing throughout the year."
• "The addition of second, or even third, scanners at existing STAND-UP MRI centers had been very successful."
• "In light of the ongoing negotiations related to the potential going private transaction, we have continued the suspension of share repurchases under our stock purchase plan that had been established in September, 2022."
• "As always, I remain grateful to our management team and all of our employees for making our company a success."

Industry Context

FONAR operates in the medical imaging industry, specializing in MRI technology and diagnostic imaging management services through its HMCA subsidiary. The reported expansion of HMCA's network and increasing scan volumes suggest a growing demand for diagnostic imaging services, particularly for specialized MRI capabilities like the STAND-UP MRI. The company's focus on patient-friendly and weight-bearing MRI technology positions it uniquely in a market driven by both technological advancements and patient comfort, differentiating it from conventional MRI providers.

Comparison to Industry Standards

• FONAR's current ratio of 8.6 is exceptionally strong, indicating high liquidity and financial stability, significantly above typical industry averages for healthcare providers or medical device manufacturers, which often range from 1.5 to 3.0.
• The growth in HMCA's managed MRI scanners from 9 in 2009 to 44 currently demonstrates substantial expansion in its diagnostic imaging services, potentially outpacing many smaller regional imaging center operators.
• The development of 'works-in-progress technology for visualizing and quantifying the cerebral hydraulics of the central nervous system' suggests innovation in a niche area, potentially differentiating FONAR from larger, more diversified medical imaging companies like Siemens Healthineers, GE Healthcare, or Philips, which focus on a broader range of imaging modalities and higher-field systems.
• The unique 'STAND-UP MRI' technology, allowing weight-bearing scans and boasting a near-zero claustrophobic rejection rate, provides a competitive advantage in patient experience compared to conventional lie-down MRI systems offered by most competitors.

Corporate Governance

Related Party Transactions

• A non-binding proposal from a group led by the Company's CEO, Timothy Damadian, and COO, Luciano Bonanni, to acquire all outstanding common stock and other securities of the Company not currently owned by the group.
• Various balance sheet items indicate ongoing related party dealings, including 'Accounts receivable related party', 'Note receivable related party', 'Prepaid expenses and other current assets related party', 'Unearned revenue on service contracts related party', and 'Due to related party medical practices'.

Stakeholder Impact

• Shareholders: Face potential liquidity from a going-private transaction, but uncertainty remains. The suspension of share repurchases removes a mechanism for returning capital, and declining net income could negatively impact share value.
• Employees: Continued growth of HMCA and expansion plans suggest job stability and potential for new opportunities within the company.
• Customers (Patients/Referring Physicians): Expansion of MRI centers and addition of high-field MRIs at existing locations will improve access to services and reduce scheduling backlogs, enhancing patient care and physician satisfaction.
• Creditors: The strong current ratio of 8.6 indicates robust liquidity and financial health, reducing credit risk.

Next Steps

• Add a second MRI scanner at an existing Nassau County center in the second quarter of Fiscal 2026.
• Manage an entirely new MRI center in Nassau County later in the fiscal year.
• Continue searching for locations to profitably enhance existing New York and Florida networks.
• Continue negotiations between the Special Committee and the CEO/COO-led group regarding the going-private transaction.
• If a definitive agreement is reached for the going-private transaction, it will require approval by common stockholders and the filing of definitive proxy materials with the SEC.

Key Dates

Recommendation

While FONAR shows modest revenue growth and strategic expansion plans for its HMCA subsidiary, the substantial decline in net income and earnings per share, driven by increased operating expenses, is a significant concern. The ongoing, non-binding going-private proposal introduces considerable uncertainty; if it materializes, it could offer a premium, but there is no assurance of its completion. The suspension of share repurchases also removes a potential support for the stock. Given the mixed financial performance and the speculative nature of the potential buyout, a 'hold' recommendation is appropriate, advising investors to await clarity on the acquisition and observe future profitability trends.

Keywords

FONAR, MR Scanning, MRI, Diagnostic Imaging, Health Management Company of America, HMCA, STAND-UP MRI, Medical Technology, Q1 Fiscal 2026, Financial Results, Going Private Transaction, Stock Repurchase, Cerebral Hydraulics, CSF